No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Canon Medical Components U.S.A., Inc. Announces Launch of New Products in the U.S., to Be on Display at RSNA 2022

Editor: What To Know

  •   The new series, designed to reduce the physical burden on patients, inherits the same IP55 standard3 compliant dust and water resistance of predecessor models allowing for frequent cleaning of the imaging portion and protecting the device in operating rooms and other environments where stray droplets are common.
  •   Intelligent NR is based on Canon’s proprietary AI technology that utilizes deep learning and has been trained using approximately 3,000 X-ray images obtained over the course of the company’s long history of developing the CXDI series of clinical imaging.
  • This new technology has the potential to support better-quality diagnoses on the front line of medical treatment and make possible high-quality imaging with reduces X-ray dosages for patients.

Canon Medical Components U.S.A., Inc., a subsidiary of Canon Inc., today announced new products line-up at the Radiology Society of North America (RSNA) conference and annual meeting, held November 27 through November 30 at the McCormick Place Convention Center in Chicago, Illinois (Booth # 8127, North Hall Level 3).

RSNA 2022 is a global radiology forum where the power of imaging, education and collaboration come to life.  Canon Medical Components U.S.A., Inc. is displaying a number of innovative products, some that are now available for the first time in the United States.

The CXDI-Pro series of wireless digital radiography (DR1) devices

The Canon CXDI-Pro wireless digital radiography systems are designed to support the demands of medical imaging departments for cost-effective solutions without compromise. These new wireless detectors provide features that optimize workflow and offer the high quality and reliability that you have come to expect from Canon.

The CXDI-Pro series employs the lightweight, CXDI-703C Wireless sensor unit, which weighs approximately 2.9 kg.  The new series, designed to reduce the physical burden on patients, inherits the same IP55 standard3 compliant dust and water resistance of predecessor models allowing for frequent cleaning of the imaging portion and protecting the device in operating rooms and other environments where stray droplets are common.  The device design also has fewer connection seams and visible screw heads in surfaces that come in contact with patients.

The CXDI-Elite series of wireless digital radiography (DR) devices

The CXDI-Elite series has high sensitivity, high image quality, and an ultra-lightweight, ergonomic design for ease of handling long battery life and AED4 function. This makes the CXDI-Elite the ideal digital radiography detector for mobile applications or any general x-ray need. The unique functions, Intelligent NR and Built-in AEC5 assistance expand the digital radiography possibilities.

New “Built-in AEC Assistance” technology for digital radiography (DR)

The CXDI-Elite series is Canon’s first digital X-ray imaging system to utilize Built-in AEC Assistance6 technology designed for general X-ray imaging. With this technology, the device’s X-ray image sensor allows for automatically terminated exposures without the use of an additional receptor (ion chamber, solid state paddle, etc.) This function works via both wireless and wired communication, which enables the optimization of X-ray dose without an external AEC sensor, even in free-position imaging such as bedside.7

New “Intelligent NR” technology for control software8 for CXDI series of digital radiography (DR) devices9

This Intelligent NR is new technology for DR control software that utilizes AI technology to reduce digital radiography image noise.  Intelligent NR is based on Canon’s proprietary AI technology that utilizes deep learning and has been trained using approximately 3,000 X-ray images obtained over the course of the company’s long history of developing the CXDI series of clinical imaging. Intelligent NR will provide radiologists with high-quality diagnostic images containing significantly less grainy noise with no noticeable loss of detail. This should make improved diagnosis possible for their patients. Intelligent NR makes it possible to reduce the noise content without losing the fine details of the anatomy, even in low dose regions. Intelligent NR results in an optimal diagnostic environment, especially for infants and pediatric patients where dose is a prevailing concern. But the image improvement will benefit all patients and exam types by providing superior images even in inherently noisy conditions such as the dense anatomy of the abdomen. This new technology has the potential to support better-quality diagnoses on the front line of medical treatment and make possible high-quality imaging with reduces X-ray dosages for patients.

These new products are now available through Canon Medical Components U.S.A., Inc.

For more information and the full list of product specifications, visit https://mcu.canon

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy